Physician profile
Ryan Alan Smith
NPI 1518100148
$2,798.15
in general payments reported to CMS, 2019-2025
19 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $356 · 2021: $191 · 2022: $242 · 2023: $312 · 2024: $471 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Education: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.48 |
| Education | $280.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $704.64 | 2021-2025 | Micra, Reveal Xt, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $633.75 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Medical Device Business Services, INC. | $280.99 | 2024 | |
| Medtronic Vascular, INC. | $272.43 | 2020 | |
| Philips North America LLC | $193.10 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $119.62 | 2019-2024 | |
| Kestra Medical Technology Services, INC. | $115.62 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.98 | 2019-2025 | Lifevest |
| Allergan, INC. | $76.08 | 2019-2021 | |
| Amgen INC. | $65.68 | 2019-2024 | Repatha |
| Biotronik INC. | $62.89 | 2019 | |
| Irhythm Technologies, INC. | $43.30 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Abiomed | $31.54 | 2023 | Impella |
| Cardiovascular Systems INC. | $23.49 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.78 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventice Services, LLC | $17.44 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.86 | 2023 | Jardiance |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.